Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.5700
-0.0300 (-5.00%)
At close: Mar 20, 2026
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 43.09 million as of March 20, 2026. Its market cap has decreased by -37.52% in one year.
Market Cap
43.09M
Enterprise Value
43.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 43.09M, a decrease of -51.64%. That is a compound annual growth rate of -13.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 43.09M | 4.31% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | 89.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 67.67M |
| Medicenna Therapeutics | 60.48M |
| NurExone Biologic | 56.11M |
| Sernova Biotherapeutics | 55.64M |
| MedMira | 45.33M |
| BriaCell Therapeutics | 44.88M |
| Microbix Biosystems | 34.56M |
| Devonian Health Group | 34.30M |